Obesity Predicts Poor Prognosis in Resectable Colon Cancer
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Obesity Predicts Poor Prognosis in Resectable Colon Cancer

PHILADELPHIA -- March 9, 2010 -- Obese patients with colon cancer are at greater risk for death or recurrent disease compared with those who are within a normal weight range, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.

“Obesity has long been established as a risk factor for cancer, but our study in colon cancer patients shows that obesity predicts a poorer prognosis after the cancer is surgically removed,” said study author Frank A. Sinicrope, MD, Mayo Clinic, Rochester, New York.

There are approximately 150,000 new cases of colon cancer diagnosed each year in the United States, and colon cancer tends to affect men and women equally, said

“More studies are now demonstrating that obesity plays a role as an independent risk factor for poorer patient prognosis that is unrelated to stroke or heart disease,” said James Abbruzzese, MD, The University of Texas M.D. Anderson Cancer Center, who is an editorial board member of Clinical Cancer Research.

Remarkably, many patients remain unaware of the risk associated between obesity and cancer. Results of a recent survey from the American Institute for Cancer Research showed that only 51% of the participants knew about the link between obesity and cancer, compared with 94% who were aware of the increased cancer risk associated with tobacco use, and 87% who knew of the increased cancer risk associated with sun exposure.

For the current study, Dr. Sinicrope and colleagues evaluated 4,381 patients with stage II or stage III colon cancer who had received adjuvant chemotherapy in clinical trials. Of these patients, 20% were obese.

Obesity was significantly linked with poorer overall survival and was independent of other variables analysed. The prognostic impact was stronger in men than in women, and men in the highest body mass index category for obesity had a 35% increased risk of death compared with normal-weight patients. The weaker effect in women is consistent with studies that have shown a lower risk of developing colon cancer in obese women compared with obese men.

“We do not know if this is due to biology or the way we measure obesity,” said Dr. Sinicrope. “Body mass index is a limited measure, and there is evidence that abdominal fat may be a better predictor of colon cancer risk and perhaps prognosis in men than in women. There is also the potential influence of menopausal status and hormone replacement therapy in women.”

SOURCE: American Association for Cancer Research

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities